|
Overview
Aspira Biosystems is
developing technology that enables the capture, with very high specificity,
of targeted proteins. Aspira is actively seeking academic and commercial
partners to develop therapeutic, medical research and industrial
applications based on Partial Molecular Imprinting (PMI), our patented protein capture platform.
Aspira is a wholly
owned subsidiary of Nanomune Technologies, Inc. Nanomune’s main
shareholders are Archangel BioVentures, LLC and Alloy Ventures, Inc.
|
|
